Sign in

CIK 0000014272 · Large accelerated filer

BRISTOL MYERS SQUIBB CO

Sign in to watch
Ticker
BMY
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
220790350
Phone
6092524621
Business address
ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NJ, 08543

Securities

  • BMY Bristol-Myers Squibb Company Common Stock NYSE
  • CELG-RI Rights NYSE
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$677,826
in 3 filings

Net −$677,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Massacesi Cristian −$403K EVP,Chief Med Offr,Head of Dev sold 25% of stake
  2. Haller Julia A −$241K Director sold 11% of stake
  3. Holzer Phil M −$34K SVP and Controller sold 3% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-04-25 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Purchase +4,250 $47.58 $202K 83,513.49
2025-02-20 BOERNER CHRISTOPHER S. Chief Executive Officer Purchase +2,000 $55.05 $110K 104,626
2025-02-14 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Purchase +1,823.49 $54.84 $100K 63,932.49
2024-11-01 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Purchase +1,830 $54.68 $100K 62,109
2023-12-05 BOERNER CHRISTOPHER S. Chief Executive Officer Purchase +2,000 $49.78 $100K 82,672
2023-11-28 BOERNER CHRISTOPHER S. Chief Executive Officer Purchase +3,071 $48.86 $150K 79,384
2023-11-20 Samuels Theodore R. II Director Purchase +8,500 $49.81 $423K 35,500

Page 1 of 1 · 7 trades